A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas

INTRODUCTION: Management of locally advanced, unresectable, or metastatic (adv/met) esophageal adenocarcinoma (EAC) follows clinical guidance for gastric cancer (GC) and gastroesophageal junction cancer (GEJC). However, evidence for these guidelines is based largely on patients with adv/met GC/GEJC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shankaran, Veena, Xiao, Hong, Bertwistle, David, Zhang, Ying, You, Min, Abraham, Pranav, Chau, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854438/
https://www.ncbi.nlm.nih.gov/pubmed/33244736
http://dx.doi.org/10.1007/s12325-020-01567-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854438/
https://www.ncbi.nlm.nih.gov/pubmed/33244736
http://dx.doi.org/10.1007/s12325-020-01567-9

Ejemplares similares